The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000441.2(SLC26A4):c.1003T>C (p.Phe335Leu)

CA253316

4842 (ClinVar)

Gene: SLC26A4
Condition: Pendred syndrome
Inheritance Mode: Autosomal recessive inheritance
UUID: fd54e511-37fc-437e-bf54-4757947ec10f
Approved on: 2020-08-25
Published on: 2020-08-26

HGVS expressions

NM_000441.2:c.1003T>C
NM_000441.2(SLC26A4):c.1003T>C (p.Phe335Leu)
NC_000007.14:g.107689054T>C
CM000669.2:g.107689054T>C
NC_000007.13:g.107329499T>C
CM000669.1:g.107329499T>C
NC_000007.12:g.107116735T>C
NG_008489.1:g.33420T>C
ENST00000644269.2:c.1003T>C
ENST00000265715.7:c.1003T>C
NM_000441.1:c.1003T>C
More

Uncertain Significance

Met criteria codes 6
PP1 PP3 PP4 PS3_Supporting PM3_Very Strong BS1_Supporting

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The c.1003T>C (p.Phe335Leu) variant has been identified in over 20 probands with Hearing loss, 6 of whom had a second pathogenic or suspected pathogenic variant in trans (PM3_VeryStrong; PMIDs: 19509082, 29293505, 25394566, 20668687, 20597900, 19426954, 19204907, 18285825, 17503324, 17357124, 17309986, 15689455, 14679580, 11317356, Laboratory for Molecular Medicine internal data). The variant has been reported to segregate with disease in one affected family member (PP1; PMID: 18285825). Multiple probands presented with hearing loss and enlarged vestibular aqueducts (EVA) which are highly specific to Pendred syndrome (PP4; PMIDs: 14679580, 18285825, 19509082, 25394566, Laboratory for Molecular Medicine internal data). The c.1003T>C (p.Phe335Leu) variant was present in 0.203% (76/30612 CI 95%) of South Asian alleles in gnomAD v2.1.1, which is a high enough frequency apply BS1_Supporting. The ClinGen Hearing Loss Expert Panel believes that the evidence for the pathogenicity of this variant for hearing loss outweighs the high allele frequency of the variant in population databases. Therefore, the BS1_Supporting code will not contribute to the overall classification. A functional study demonstrates that the p.Phe335Leu variant may impact protein function (PS3_Supporting; PMID: 19204907). Finally, the REVEL computational prediction analysis tool produced a score of 0.828, which is above the threshold necessary to apply PP3. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Pendred syndrome based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PM3_VeryStrong, PS3_Supporting, BS1_Supporting, PP1, PP3, PP4.
Met criteria codes
PP1
PMID: 18285825
PP3
REVEL: 0.858
PP4
PMID: 18285825
PS3_Supporting
PMID: 19204907
PM3_Very Strong
6 compound het cases

BS1_Supporting
0.203% (76/30612 CI 95%) of South Asian alleles in gnomAD v2.1.1
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.